A new study suggests that the rollout of vaccines against the coronavirus disease 2019 (COVID-19) pandemic may be significant not only in preventing infections by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) but other endemic and pandemic-potential coronaviruses (CoVs) as well.
A preprint version of the study is available on the bioRxiv* server, while the article undergoes peer review.
SARS-CoV-2 vaccines elicit cross-reactive CoV antibodies in humans
The use of SARS-CoV-2 vaccines in humans was associated with marked increases in antibodies against this virus, of course, but also of cross-reactive antibodies against SARS-CoV-1 and the common cold coronavirus OC43 in people with or without a history of infection with SARS-CoV-2.
